Breakthrough Therapeutic Tool Presented to 400 Leading Hair Loss Surgeons
A unique therapeutic tool for hair loss treatment was presented to 400 hair restoration surgeons and experts at a recent conference. The Scalproller, developed by Nanogen, is rapidly becoming a key component to various hair loss treatment programmes.
London, United Kingdom, August 13, 2009 --(PR.com)-- A unique Titanium microneedle roller called the Scalproller™ was unveiled by the British biotech Nanogen at a recent conference in Amsterdam. Over 400 of the world’s leading hair loss surgeons and trichologists visited the recent July ISHRS annual meeting where the Scalproller was first exhibited.
Nanogen’s Scalproller has 4 clinical applications to enhance existing hair loss treatments. When using the Scalproller, penetration of Minoxidil – a prescription hair loss treatment, is increased by over 5 times on treated skin compared to untreated skin. Additionally, Scalproller therapy fades and removes donor scars from hair transplant surgery. Cutting edge hair loss treatment Platelet Rich Plasma (PRP) also requires Scalproller treatment to activate the growth factors. Furthermore, the latest research on behalf of Intercytex by Dr Bessam Farjo, and pioneering studies by Dr George Cotsarelis provide evidence that Scalproller therapy may produce new hair growth independently of any other treatment.
Dr. Farjo, immediate past president of the ISHRS and also an attendee of the conference, was impressed with this innovation, “Nanogen's Scalproller device is interesting in that it uses concepts of recent leading-edge hair loss research. Certainly, as demonstrated by the recent Intercytex cell therapy trials and previous work on the animal model by Cotsarelis et al., there is good research data to show stimulation of hair growth in response to skin stimulation or injury. Studies have also shown that needle holes of 0.5mm depth or more penetrate the skin sufficiently to increase the diffusion of compounds of similar molecular weight and charge to Minoxidil.”
The Scalproller is unique in that it is the only microneedle therapy roller specifically designed for hair loss treatment. According to Nanogen Medical Director Elliot Isaacs, “The previous technology for dermatological purposes was insufficient to meet the durability and accuracy requirements of a professional medical device. Harder titanium needles and precise European engineering techniques were necessary to produce a roller that will stay sharp for over 4 months, and perforate the skin to the exact depth every time.”
The Scalproller, already the subject of several international patents pending, was enthusiastically received by the hair loss and surgical community. Both the home use versions and the longer 1 & 2mm clinical models are already in use in a range of professional practices, and several applications have been made to Nanogen to conduct new research utilising the Scalproller.
###
Nanogen’s Scalproller has 4 clinical applications to enhance existing hair loss treatments. When using the Scalproller, penetration of Minoxidil – a prescription hair loss treatment, is increased by over 5 times on treated skin compared to untreated skin. Additionally, Scalproller therapy fades and removes donor scars from hair transplant surgery. Cutting edge hair loss treatment Platelet Rich Plasma (PRP) also requires Scalproller treatment to activate the growth factors. Furthermore, the latest research on behalf of Intercytex by Dr Bessam Farjo, and pioneering studies by Dr George Cotsarelis provide evidence that Scalproller therapy may produce new hair growth independently of any other treatment.
Dr. Farjo, immediate past president of the ISHRS and also an attendee of the conference, was impressed with this innovation, “Nanogen's Scalproller device is interesting in that it uses concepts of recent leading-edge hair loss research. Certainly, as demonstrated by the recent Intercytex cell therapy trials and previous work on the animal model by Cotsarelis et al., there is good research data to show stimulation of hair growth in response to skin stimulation or injury. Studies have also shown that needle holes of 0.5mm depth or more penetrate the skin sufficiently to increase the diffusion of compounds of similar molecular weight and charge to Minoxidil.”
The Scalproller is unique in that it is the only microneedle therapy roller specifically designed for hair loss treatment. According to Nanogen Medical Director Elliot Isaacs, “The previous technology for dermatological purposes was insufficient to meet the durability and accuracy requirements of a professional medical device. Harder titanium needles and precise European engineering techniques were necessary to produce a roller that will stay sharp for over 4 months, and perforate the skin to the exact depth every time.”
The Scalproller, already the subject of several international patents pending, was enthusiastically received by the hair loss and surgical community. Both the home use versions and the longer 1 & 2mm clinical models are already in use in a range of professional practices, and several applications have been made to Nanogen to conduct new research utilising the Scalproller.
###
Contact
Nanogen
Toby Cobbledick
+44 (0)20 8458 2500
www.nanogen.org
Toby Cobbledick
+44 (0)20 8458 2500
www.nanogen.org
Contact
Categories